FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
First Relief v1
K Number: K202940
·
Decision Dec 29, 2020
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
5
Applicant Total
14
Review Days
90
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- First Relief v1
- K Number
- K202940
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 876.5340
- Medical Specialty
- Gastroenterology, Urology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Dyansys, Inc.
- Date Received
- September 30, 2020
- Decision Date
- December 29, 2020
- Product Code
- QHH
- Advisory Committee
- Gastroenterology, Urology
- Review Advisory Committee
- NE
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QHH | Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs) | FDA class 2 | Gastroenterology, Urology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (QHH), ordered by most recent decision date.
NeurAxis IB-Stim (01-1020)
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
NeurAxis IB-Stim (01-1020)
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
NeurAxis IB-Stim (01-1020)
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
TEA Device
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
IB-Stim
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
Other Clearances by Dyansys, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K221425 | Primary Relief | Sep 13, 2022 | Substantially Equivalent |
| K221231 | Drug Relief v1 | Jun 6, 2022 | Substantially Equivalent |
| K220397 | ANSiStim-PP | May 12, 2022 | Substantially Equivalent |
| K213188 | Primary Relief | Jan 31, 2022 | Substantially Equivalent |
| K212859 | First Relief | Dec 20, 2021 | Substantially Equivalent |
| K211971 | Drug Relief v1 | Nov 5, 2021 | Substantially Equivalent |
| K173861 | Drug Relief | May 2, 2018 | Substantially Equivalent |
| K170391 | ANSiStim-PP | Mar 9, 2017 | Substantially Equivalent |
| K141168 | ANSISTIM | May 15, 2015 | Substantially Equivalent |
| K091397 | ECSCOPE 200 | Jul 8, 2009 | Substantially Equivalent |